SMCI
Super Micro Computer
-- 42.000 NVDA
NVIDIA
-- 138.630 TSLA
Tesla
-- 357.090 MSTR
MicroStrategy
-- 380.300 MARA
MARA Holdings
-- 25.630 
Update
$Clearside Biomedical (CLSD.US)$ Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes
2 MINUTES AGO, 6:30 AM EDT
VIA GLOBENEWSWIRE
Maintained Stable Visual Acuity and Anatomical Control Over 9 Months -
- Positive Safety Profile with No Ocular or Treatment-Related Serious Adverse Events -
- 67% of CLS-AX Participants Did Not Require Any Additional Treatment up to 6 Months -
- Reduced Treatment Burden by 84% Over 6 Months -
- Webcast and Conference Call Today at 8:00 A.M. ET with Management and Key Opinion Leader and Board-Certified Retinal Specialist, Roger Goldberg, M.D., MBA -
2 MINUTES AGO, 6:30 AM EDT
VIA GLOBENEWSWIRE
Maintained Stable Visual Acuity and Anatomical Control Over 9 Months -
- Positive Safety Profile with No Ocular or Treatment-Related Serious Adverse Events -
- 67% of CLS-AX Participants Did Not Require Any Additional Treatment up to 6 Months -
- Reduced Treatment Burden by 84% Over 6 Months -
- Webcast and Conference Call Today at 8:00 A.M. ET with Management and Key Opinion Leader and Board-Certified Retinal Specialist, Roger Goldberg, M.D., MBA -
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment